These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 30211828)
41. Cytomegalovirus: an unlikely ally in the fight against blood cancers? Bigley AB; Baker FL; Simpson RJ Clin Exp Immunol; 2018 Sep; 193(3):265-274. PubMed ID: 29737525 [TBL] [Abstract][Full Text] [Related]
42. Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission. Pighi C; Rotili A; De Luca M; Chiurchiù S; Calò Carducci FI; Rossetti C; Cifaldi L; Bei R; Caforio L; Bernardi S; Palma P; Amodio D Viruses; 2024 May; 16(5):. PubMed ID: 38793661 [TBL] [Abstract][Full Text] [Related]
43. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts. Newhook N; Fudge N; Grant M Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279 [TBL] [Abstract][Full Text] [Related]
44. Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients. Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Heredia G; Pérez-Sáez MJ; Vila J; Costa-García M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M Am J Transplant; 2020 Mar; 20(3):663-676. PubMed ID: 31612635 [TBL] [Abstract][Full Text] [Related]
45. Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients. Vietzen H; Hartenberger S; Jaksch P; Puchhammer-Stöckl E J Heart Lung Transplant; 2021 Sep; 40(9):900-904. PubMed ID: 34183227 [TBL] [Abstract][Full Text] [Related]
46. The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection. López-Botet M; Muntasell A; Vilches C Semin Immunol; 2014 Apr; 26(2):145-51. PubMed ID: 24666761 [TBL] [Abstract][Full Text] [Related]
47. Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT. van der Ploeg K; Sottile R; Kontopoulos T; Shaffer BC; Papanicolaou GA; Maloy MA; Cho C; Robinson KS; Perales MA; Le Luduec JB; Hsu KC Blood Adv; 2023 Oct; 7(19):5784-5798. PubMed ID: 37196646 [TBL] [Abstract][Full Text] [Related]
49. NKG2C Deletion Is a Risk Factor for Human Cytomegalovirus Viremia and Disease After Lung Transplantation. Vietzen H; Pollak K; Honsig C; Jaksch P; Puchhammer-Stöckl E J Infect Dis; 2018 Feb; 217(5):802-806. PubMed ID: 29220498 [TBL] [Abstract][Full Text] [Related]
50. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation. Davis ZB; Cooley SA; Cichocki F; Felices M; Wangen R; Luo X; DeFor TE; Bryceson YT; Diamond DJ; Brunstein C; Blazar BR; Wagner JE; Weisdorf DJ; Horowitz A; Guethlein LA; Parham P; Verneris MR; Miller JS Biol Blood Marrow Transplant; 2015 Sep; 21(9):1653-62. PubMed ID: 26055301 [TBL] [Abstract][Full Text] [Related]
51. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Muntasell A; Vilches C; Angulo A; López-Botet M Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990 [TBL] [Abstract][Full Text] [Related]
52. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Muntasell A; López-Montañés M; Vera A; Heredia G; Romo N; Peñafiel J; Moraru M; Vila J; Vilches C; López-Botet M Eur J Immunol; 2013 Dec; 43(12):3268-78. PubMed ID: 24030638 [TBL] [Abstract][Full Text] [Related]
53. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients. Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V Front Immunol; 2018; 9():917. PubMed ID: 29867932 [TBL] [Abstract][Full Text] [Related]
54. Functional and clinical consequences of changes to natural killer cell phenotypes driven by chronic cytomegalovirus infections. Lee S; Doualeh M; Affandi JS; Makwana N; Irish A; Price P J Med Virol; 2019 Jun; 91(6):1120-1127. PubMed ID: 30636352 [TBL] [Abstract][Full Text] [Related]
56. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection. Holder KA; Lajoie J; Grant MD Front Immunol; 2018; 9():2494. PubMed ID: 30483249 [TBL] [Abstract][Full Text] [Related]
57. Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies. Muccio L; Bertaina A; Falco M; Pende D; Meazza R; Lopez-Botet M; Moretta L; Locatelli F; Moretta A; Della Chiesa M Haematologica; 2016 Mar; 101(3):371-81. PubMed ID: 26659918 [TBL] [Abstract][Full Text] [Related]
58. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492 [TBL] [Abstract][Full Text] [Related]
59. Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction-free survival. Greenland NY; Deiter F; Calabrese DR; Hays SR; Kukreja J; Leard LE; Kolaitis NA; Golden JA; Singer JP; Greenland JR Clin Transplant; 2022 Jun; 36(6):e14639. PubMed ID: 35246990 [TBL] [Abstract][Full Text] [Related]
60. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus. Hendricks DW; Balfour HH; Dunmire SK; Schmeling DO; Hogquist KA; Lanier LL J Immunol; 2014 May; 192(10):4492-6. PubMed ID: 24740502 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]